Cargando…

Factors Limiting Subgroup Analysis in Cost-Effectiveness Analysis and a Call for Transparency

The use of population averages in cost-effectiveness analysis may hide important differences across subgroups, potentially resulting in suboptimal resource allocation, reduced population health and/or increased health inequalities. We discuss the factors that limit subgroup analysis in cost-effectiv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shields, Gemma E., Wilberforce, Mark, Clarkson, Paul, Farragher, Tracey, Verma, Arpana, Davies, Linda M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Practical Application
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553493/ https://www.ncbi.nlm.nih.gov/pubmed/34713422 http://dx.doi.org/10.1007/s40273-021-01108-4

Ejemplares similares

The Broader Opportunity Costs in the Broader Cost-Effectiveness Analysis Framework
por: Vallejo-Torres, Laura
Publicado: (2023)

Dealing with Bad Risk in Cost-Effectiveness Analysis: The Cost-Effectiveness Risk-Aversion Curve
por: Sendi, Pedram
Publicado: (2020)

The Challenge of Transparency and Validation in Health Economic Decision Modelling: A View from Mount Hood
por: Kent, Seamus, et al.
Publicado: (2019)

Sensitivity Analysis for Not-at-Random Missing Data in Trial-Based Cost-Effectiveness Analysis: A Tutorial
por: Leurent, Baptiste, et al.
Publicado: (2018)

Utilising Patient and Public Involvement in Stated Preference Research in Health: Learning from the Existing Literature and a Case Study
por: Shields, Gemma E., et al.
Publicado: (2020)

One-Way Sensitivity Analysis for Probabilistic Cost-Effectiveness Analysis: Conditional Expected Incremental Net Benefit
por: McCabe, Christopher, et al.
Publicado: (2019)

Extended Cost-Effectiveness Analysis for Health Policy Assessment: A Tutorial
por: Verguet, Stéphane, et al.
Publicado: (2016)

The Value of Health in a Cost-Effectiveness Analysis: Theory Versus Practice
por: Wouterse, Bram, et al.
Publicado: (2023)

Achieving Appropriate Model Transparency: Challenges and Potential Solutions for Making Value-Based Decisions in the United States
por: Carlson, Josh J., et al.
Publicado: (2019)

A Practical Guide to Modeling and Conducting a Cost-Effectiveness Analysis of Companion Biomarker Tests for Targeted Therapies Using R: Tutorial Paper
por: Seo, Mikyung Kelly, et al.
Publicado: (2021)

A Guide to Handling Missing Data in Cost-Effectiveness Analysis Conducted Within Randomised Controlled Trials
por: Faria, Rita, et al.
Publicado: (2014)

Estimating Marginal Healthcare Costs Using Genetic Variants as Instrumental Variables: Mendelian Randomization in Economic Evaluation
por: Dixon, Padraig, et al.
Publicado: (2016)

Exploring the Integration of Environmental Impacts in the Cost Analysis of the Pilot MEL-SELF Trial of Patient-Led Melanoma Surveillance
por: Williams, Jake T. W., et al.
Publicado: (2022)

Standardized Questionnaire for the Measurement, Valuation, and Estimation of Costs of Informal Care Based on the Opportunity Cost and Proxy Good Method
por: Landfeldt, Erik, et al.
Publicado: (2018)

Striving for a Societal Perspective: A Framework for Economic Evaluations When Costs and Effects Fall on Multiple Sectors and Decision Makers
por: Walker, Simon, et al.
Publicado: (2019)

Modelling the Epidemiology of Infectious Diseases for Decision Analysis: A Primer
por: Jit, Mark, et al.
Publicado: (2012)

Geographic Resource Allocation Based on Cost Effectiveness: An Application to Malaria Policy
por: Drake, Tom L., et al.
Publicado: (2017)

Different Methods for Modelling Severe Hypoglycaemic Events: Implications for Effectiveness, Costs and Health Utilities
por: Keeney, Edna, et al.
Publicado: (2018)

Impact of a New Cost-Effectiveness Threshold Implementation on Cancer Formulary Decisions in Jordan
por: Treish, Imad, et al.
Publicado: (2021)

Cost‑Effectiveness Risk‑Aversion Curves: Comparison of Risk-Adjusted Performance Measures and Expected-Utility Approaches
por: Elbasha, Elamin H.
Publicado: (2022)

Valuation of Costs in Health Economics During Financial and Economic Crises: A Case Study from Lebanon
por: Dahham, Jalal, et al.
Publicado: (2022)

A Simple Cost-Effectiveness Model of Screening: An Open-Source Teaching and Research Tool Coded in R
por: Lin, Yi-Shu, et al.
Publicado: (2023)

The Application and Implications of Novel Deterministic Sensitivity Analysis Methods
por: Vreman, Rick A., et al.
Publicado: (2020)

How to Cost the Implementation of Major System Change for Economic Evaluations: Case Study Using Reconfigurations of Specialist Cancer Surgery in Part of London, England
por: Clarke, Caroline S., et al.
Publicado: (2021)

A Practical Guide for Using Registry Data to Inform Decisions About the Cost Effectiveness of New Cancer Drugs: Lessons Learned from the PHAROS Registry
por: Blommestein, Hedwig M., et al.
Publicado: (2015)

Probabilistic One-Way Sensitivity Analysis with Multiple Comparators: The Conditional Net Benefit Frontier
por: McCabe, Christopher, et al.
Publicado: (2020)

Future Trends and the Pace of Change: Are We Ready?: The COVID-19 pandemic has presented an undeniable case for change. Life, work and organizations will never be “back to normal.” This opens up massive opportunities to raise our awareness of future trends and to elevate our profession, build resilience, increase our influence and visibility, and infuse futuristic competencies into our educational programs and practices.
por: Farr, Linda T.
Publicado: (2021)

Time to See the Difference: Video Capture for Patient-Centered Clinical Trials
por: Davies, Elin Haf, et al.
Publicado: (2022)

Weighing Clinical Evidence Using Patient Preferences: An Application of Probabilistic Multi-Criteria Decision Analysis
por: Broekhuizen, Henk, et al.
Publicado: (2016)

Evaluating Equity in Health Financing Using Benefit Incidence Analysis: A Framework for Accounting for Quality of Care
por: Asante, Augustine, et al.
Publicado: (2020)

So You Want to Build Your Disease’s First Online Patient Registry: An Educational Guide for Patient Organizations Based on US and European Experience
por: Wicks, Paul, et al.
Publicado: (2023)

Value-Based Assessment of New Medical Technologies: Towards a Robust Methodological Framework for the Application of Multiple Criteria Decision Analysis in the Context of Health Technology Assessment
por: Angelis, Aris, et al.
Publicado: (2016)

Balanced assessment systems revisited
por: Dankó, Dávid, et al.
Publicado: (2017)

Developing Open-Source Models for the US Health System: Practical Experiences and Challenges to Date with the Open-Source Value Project
por: Jansen, Jeroen P., et al.
Publicado: (2019)

Putting Stakeholder Engagement at the Center of Health Economic Modeling for Health Technology Assessment in the United States
por: Xie, Richard Z., et al.
Publicado: (2021)

EuroQol Protocols for Time Trade-Off Valuation of Health Outcomes
por: Oppe, Mark, et al.
Publicado: (2016)

Can the UK ‘Netflix’ Payment Model Boost the Antibacterial Pipeline?
por: Leonard, Colm, et al.
Publicado: (2023)

Years of life lost to COVID-19 in 20 countries
por: Williams, Greg, et al.
Publicado: (2022)

Preferred Reporting Items for Studies Mapping onto Preference-Based Outcome Measures: The MAPS Statement
por: Petrou, Stavros, et al.
Publicado: (2015)

The variant call format and VCFtools
por: Danecek, Petr, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_a4tbiv1dtcb6747ctf6fbac5il